Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces Formation of New Bruker Spatial Biology Division — Oct 11th, 2024

Bruker Spatial Biology Offers the Widest Range of Industry-leading Multiomic Spatial Biology Platforms to Scientists Globally BILLERICA, Mass., October 11, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, off...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress — Oct 17th, 2024

Biognosys AG Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectro...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products — Oct 17th, 2024

BILLERCA, Mass., October 17, 2024--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the "928 Patent"), which has been asserted by 10x Ge...

BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division — Oct 17th, 2024

Bruker Corporation BRKR recently announced the formation of a new division, Bruker Spatial Biology, to offer the most diverse and comprehensive solutions for spatial biology. It operates coordination across three entities: the two businesses of NanoString Technologies and Canopy Bioscience...

Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? — Oct 17th, 2024

We recently compiled a list of the 7 Most Profitable Mid-Cap Stocks To Invest In.In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other profitable mid-cap stocks. Inflation Data Raises Concerns On October 10, the market faced a dec...

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics — Oct 21st, 2024

Bruker's timsTOF Ultra 2 Mass Spectrometer (Graphic: Business Wire) Visualization and statistical analysis of 4D-Multiomics data from MetaboScape® (Graphic: Business Wire) Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity L...